vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Microchip Technology (MCHP). Click either name above to swap in a different company.

Microchip Technology is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Everus Construction Group, Inc.). Microchip Technology runs the higher net margin — 11.0% vs 5.5%, a 5.5% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -72.2%). Microchip Technology produced more free cash flow last quarter ($242.8M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 2.8%).

Microchip Technology Incorporated is an American publicly traded semiconductor corporation that manufactures microcontroller, mixed-signal, analog, and Flash-IP integrated circuits.

ECG vs MCHP — Head-to-Head

Bigger by revenue
MCHP
MCHP
1.3× larger
MCHP
$1.3B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+105.3% gap
ECG
33.2%
-72.2%
MCHP
Higher net margin
MCHP
MCHP
5.5% more per $
MCHP
11.0%
5.5%
ECG
More free cash flow
MCHP
MCHP
$219.3M more FCF
MCHP
$242.8M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
2.8%
MCHP

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
ECG
ECG
MCHP
MCHP
Revenue
$1.0B
$1.3B
Net Profit
$55.3M
$144.2M
Gross Margin
11.6%
61.0%
Operating Margin
6.8%
16.6%
Net Margin
5.5%
11.0%
Revenue YoY
33.2%
-72.2%
Net Profit YoY
60.4%
8.9%
EPS (diluted)
$1.09
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
MCHP
MCHP
Q1 26
$1.3B
Q4 25
$1.0B
$1.2B
Q3 25
$986.8M
$1.1B
Q2 25
$921.5M
$1.1B
Q1 25
$826.6M
$970.5M
Q4 24
$759.6M
$1.0B
Q3 24
$761.0M
$1.2B
Q2 24
$703.4M
$1.2B
Net Profit
ECG
ECG
MCHP
MCHP
Q1 26
$144.2M
Q4 25
$55.3M
$62.7M
Q3 25
$57.0M
$41.7M
Q2 25
$52.8M
$-18.6M
Q1 25
$36.7M
$-154.6M
Q4 24
$34.5M
$-53.6M
Q3 24
$41.8M
$78.4M
Q2 24
$39.0M
$129.3M
Gross Margin
ECG
ECG
MCHP
MCHP
Q1 26
61.0%
Q4 25
11.6%
59.6%
Q3 25
12.6%
55.9%
Q2 25
13.0%
53.6%
Q1 25
11.2%
51.6%
Q4 24
11.4%
54.7%
Q3 24
11.8%
57.4%
Q2 24
12.6%
59.4%
Operating Margin
ECG
ECG
MCHP
MCHP
Q1 26
16.6%
Q4 25
6.8%
12.8%
Q3 25
7.3%
7.8%
Q2 25
7.9%
3.0%
Q1 25
6.2%
-10.3%
Q4 24
6.1%
3.0%
Q3 24
7.1%
12.6%
Q2 24
7.3%
17.7%
Net Margin
ECG
ECG
MCHP
MCHP
Q1 26
11.0%
Q4 25
5.5%
5.3%
Q3 25
5.8%
3.7%
Q2 25
5.7%
-1.7%
Q1 25
4.4%
-15.9%
Q4 24
4.5%
-5.2%
Q3 24
5.5%
6.7%
Q2 24
5.5%
10.4%
EPS (diluted)
ECG
ECG
MCHP
MCHP
Q1 26
$0.21
Q4 25
$1.09
$0.06
Q3 25
$1.11
$0.03
Q2 25
$1.03
$-0.09
Q1 25
$0.72
$-0.29
Q4 24
$0.68
$-0.10
Q3 24
$0.82
$0.14
Q2 24
$0.76
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
MCHP
MCHP
Cash + ST InvestmentsLiquidity on hand
$240.3M
Total DebtLower is stronger
$281.5M
$5.5B
Stockholders' EquityBook value
$629.8M
$6.4B
Total Assets
$1.7B
$14.4B
Debt / EquityLower = less leverage
0.45×
0.85×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
MCHP
MCHP
Q1 26
$240.3M
Q4 25
$250.7M
Q3 25
$236.8M
Q2 25
$566.5M
Q1 25
$771.7M
Q4 24
$586.0M
Q3 24
$553.0K
$286.1M
Q2 24
$315.1M
Total Debt
ECG
ECG
MCHP
MCHP
Q1 26
$5.5B
Q4 25
$281.5M
$5.4B
Q3 25
$285.1M
$5.4B
Q2 25
$288.6M
$5.5B
Q1 25
$292.1M
$5.6B
Q4 24
$295.6M
$6.7B
Q3 24
$6.4B
Q2 24
$6.2B
Stockholders' Equity
ECG
ECG
MCHP
MCHP
Q1 26
$6.4B
Q4 25
$629.8M
$6.6B
Q3 25
$573.0M
$6.7B
Q2 25
$514.4M
$6.9B
Q1 25
$460.2M
$7.1B
Q4 24
$422.6M
$6.0B
Q3 24
$453.3M
$6.3B
Q2 24
$490.0M
$6.4B
Total Assets
ECG
ECG
MCHP
MCHP
Q1 26
$14.4B
Q4 25
$1.7B
$14.3B
Q3 25
$1.6B
$14.5B
Q2 25
$1.5B
$15.0B
Q1 25
$1.4B
$15.4B
Q4 24
$1.3B
$15.6B
Q3 24
$1.3B
$15.6B
Q2 24
$15.8B
Debt / Equity
ECG
ECG
MCHP
MCHP
Q1 26
0.85×
Q4 25
0.45×
0.82×
Q3 25
0.50×
0.80×
Q2 25
0.56×
0.80×
Q1 25
0.63×
0.80×
Q4 24
0.70×
1.12×
Q3 24
1.02×
Q2 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
MCHP
MCHP
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
$242.8M
FCF MarginFCF / Revenue
2.3%
18.5%
Capex IntensityCapex / Revenue
2.4%
1.1%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$871.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
MCHP
MCHP
Q1 26
Q4 25
$48.2M
$341.4M
Q3 25
$76.2M
$88.1M
Q2 25
$25.3M
$275.6M
Q1 25
$7.1M
$205.9M
Q4 24
$271.5M
Q3 24
$78.9M
$43.6M
Q2 24
$377.1M
Free Cash Flow
ECG
ECG
MCHP
MCHP
Q1 26
$242.8M
Q4 25
$23.5M
$318.9M
Q3 25
$65.7M
$51.6M
Q2 25
$12.3M
$257.7M
Q1 25
$-11.4M
$191.7M
Q4 24
$253.4M
Q3 24
$60.9M
$22.8M
Q2 24
$304.2M
FCF Margin
ECG
ECG
MCHP
MCHP
Q1 26
18.5%
Q4 25
2.3%
26.9%
Q3 25
6.7%
4.5%
Q2 25
1.3%
24.0%
Q1 25
-1.4%
19.8%
Q4 24
24.7%
Q3 24
8.0%
2.0%
Q2 24
24.5%
Capex Intensity
ECG
ECG
MCHP
MCHP
Q1 26
1.1%
Q4 25
2.4%
1.9%
Q3 25
1.1%
3.2%
Q2 25
1.4%
1.7%
Q1 25
2.2%
1.5%
Q4 24
1.8%
Q3 24
2.4%
1.8%
Q2 24
5.9%
Cash Conversion
ECG
ECG
MCHP
MCHP
Q1 26
Q4 25
0.87×
5.44×
Q3 25
1.34×
2.11×
Q2 25
0.48×
Q1 25
0.19×
Q4 24
Q3 24
1.89×
0.56×
Q2 24
2.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

MCHP
MCHP

Segment breakdown not available.

Related Comparisons